mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0009 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0009 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |